Kevin Koch, President & CSO at ARRAY BIOPHARMA INC (ARRY), sold 20,000 shares at $14.06 ($281K) on 2007-02-05, disclosed to the SEC on 2007-02-07.
Scheduled sale ($281k) by President & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EWTX | SELL | 2025-05-07 | $141K | — | Filing → |
| EWTX | SELL | 2025-03-11 | $3K | — | Filing → |
| EWTX | SELL | 2025-02-07 | $547K | — | Filing → |